Resources
Will the origins of the coronavirus name lead us to the answers for a cure? The peptide therapeutics combating COVID-19
The latest peptide research around the world focused on defeating coronavirus.
Latest Presidential visit at the CDC showcases CSBio's peptide synthesizers
With the growing threat of coronavirus in the United States, President Donald Trump recently made a visit to the Centers for Disease Control and Prevention (CDC).
In the tour of the CDC facilities and in the room that the President is speaking along with Health and Humans Services Secretary (HHS) Alex Azar, various images could be seen of CSBio's peptide synthesizer showcased in their background.
The CDC is the leading national public health institute of the United States, and is a United States federal agency under the Department of Health and Human Services.
CSBio serves the CDC, the leading national public health institute in the United.
CSBio has been excited to serve and see the utilization of our research scale peptide synthesizers at the CDC over the many last years, and CSBio supports the CDC's peptide synthesizer needs as they have continued to expand their peptide synthesis capabilities.
While it's been many years since the CDC has acquired their first peptide synthesizer, and we still continue to support their systems that are in use today, it's not every day that you see CSBio's peptide synthesizers in newspapers and news articles around the world.
Take a look at two stories from around the world that reported about the President's visit that show some good images of CSBio's peptide synthesizers in the background: Good Morning America - "Trump touring CDC headquarters in Atlanta", and New York Post - "Trump visits CDC for coronavirus update, praises scientists".
Related Posts
Resources
Synthesizing a 132-mer peptide with high purity
Synthesis of peptides at any length requires extreme attention to detail for accuracy and purity of the desired compound...
Resources
From peptide drug discovery, through process development, to commerical scale manufacturing
When a multinational pharmaceutical company initiated their in-house manufacturing of peptides in the early phases of drug discovery...
About Us
CSBio is a leading peptide and instrumentation manufacturing company located on the edge of Silicon Valley in Menlo Park, California.
CSBio provides nonGMP and cGMP peptides, peptide APIs, research scale peptide synthesizers, commerical scale peptide synthesizers, DNA/RNA oligonucleotide synthesizers, and preparative HPLC purification equipment.